News
The first ever treatment for Australians with a rare neurodegenerative disease could help slow the progression of its damage ...
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd.
For chronic pain patients, though, the brain interprets even neutral sensations as pain and suffering. In effect, pain ...
Therapeutic development for central nervous system (CNS) disorders remains hindered by inefficient drug penetration across the blood–brain barrier (BBB) and a lack of spatiotemporal precision ...
Transferrin receptor 1 (TfR1) is a ubiquitously expressed receptor characterized by rapid internalization kinetics and efficient receptor recycling, making it an attractive target for drug delivery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results